PrEP Toolkit/Resources

emptyimage-01Implementing PrEP in Clinical Practice: Assessing HIV Risk and Supporting PrEP Adherence to Maximize HIV Prevention

In this conversation-style Webcast, leading experts in the fields of human immunodeficiency virus (HIV) prevention and pre-exposure prophylaxis (PrEP) discuss features of a sexual history that identify patients at risk of HIV transmission as PrEP candidates, approaches for implementing the PrEP cascade in clinical practice for patients at high risk of HIV, and the impact of adherence and nondaily dosing on PrEP effectiveness. Additionally, the panel discusses adherence-related challenges that patients taking PrEP may encounter and offers tools to maximize the effectiveness of PrEP as an HIV-prevention strategy. 



PrEP Points

Taking certain HIV medicines as pre-exposure prophylaxis (PrEP) can lower your risk of sexually transmitted HIV by more than 90%. If you are in an ongoing relationship with a partner who has HIV, have sex without a condom with someone who could have HIV, and/or inject drugs or share drug equipment, you are at high risk of HIV and may want to consider this approach to PrEP. In the video on the left, two experts on PrEP discuss how taking specific medications can prevent HIV and list important questions to ask your provider if you are interested in PrEP.


Below are several helpful e-briefs designed to help providers implement PrEP in HIV prevention:


Cultural Competence and Taking Patient Sexual Histories





Steps to PrEP





Accessing PrEP



Download article:  USA Today Features HealthHIV’s PrEP Work on World AIDS Day.


For additional information about HealthHIV’s programs, initiatives, or coalitions, please click here to email, or call 202.232.6749.